Gemcitabine (elaidate) is primarily used in the field of oncology as a chemotherapeutic agent. It is specifically designed to treat various types of cancer, including pancreatic, breast, ovarian, and non-small cell lung cancer. The compound works by inhibiting DNA synthesis, thereby preventing the proliferation of cancer cells. It is often administered intravenously and is commonly used in combination with other chemotherapy drugs to enhance its efficacy. Additionally, Gemcitabine (elaidate) is being researched for its potential in treating other malignancies and its role in targeted cancer therapies. Its lipid-modified form allows for improved drug delivery and reduced side effects, making it a valuable option in cancer treatment regimens.